Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology. 2015 Nov; 62(5):1353–63.
Ly KN, Hughes EM, Jiles RB, et al. Rising mortality associated with hepatitis C virus in the United States, 2003–2013. Clin Infect Dis. 2016. doi:10.1093/cid/ciw111.
Important study showing that mortality from hepatitis C in the USA has surpassed mortality from all other notifiable infectious diseases
Ryerson AB, Eheman CR, Altekruse SF, et al. Annual Report to the Nation on the Status of Cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer. 2016. doi:10.1002/cncr.29936
van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;24:2584–93.CrossRefGoogle Scholar
Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, et al. Annual Report to the Nation on the Status of Cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer. 2016;122(9):1312–37.
Holmberg SD, Spradling PR, Moorman AC, et al. Hepatitis C in the United States. N Engl J Med. 2013;20:1859–61.CrossRefGoogle Scholar
Denniston MM, Klevens RM, McQuillan GM, et al. Awareness of infection, knowledge of hepatitis C, and medical follow‐up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008. Hepatology. 2012;55(6):1652–61.CrossRefPubMedPubMedCentralGoogle Scholar
Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recomm Rep. 2012;61(RR-4):1–32.PubMedGoogle Scholar
U.S. Preventive Services Task Force. Final Update Summary: hepatitis C: Screening. U.S. Preventive Services Task Force. July 2015. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/hepatitis-c-screening
Hill A, Cooke G. Hepatitis C can be cured globally, but at what cost. Science. 2014;345(6193):141–2.CrossRefPubMedGoogle Scholar
Arora S, Thornton K, Komaromy M, et al. Demonopolizing medical knowledge. Acad Med. 2014;89(1):30–2.CrossRefPubMedGoogle Scholar
U.S. Health Resources and Services Administration, HRSA medically underserved areas find. U.S. Health Resources and Services Administration. Data as of 4/7/2016. Available from: http://datawarehouse.hrsa.gov/tools/analyzers/muafind.aspx
Murphy SL, Xu J, Kochanek KD, Bastian BA. Deaths: final data for 2013. Natl Vital Stat Rep. 2016;64(2):1–119.PubMedGoogle Scholar
Arora S, Thornton K, Murata G, Deming P, Kalishman S, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011;364(23):2199–207.CrossRefPubMedGoogle Scholar
Chhatwal J, Wang X, Ayer T, et. al. Hepatitis C disease burden in the United States in the era of oral direct‐acting antivirals. Hepatology. 2016. doi:10.1002/hep.28571
Describes an important mathematical model, which demonstrates that increased hepatitis C treatment capacity is essential in decreasing mortality and morbidity from hepatitis C in the era of direct-acting antivirals
Nafisi S. Primary care physicians utilizing the ECHO model equally effective as subspecialist treating HCV using DAA-only regimens: results of the ECHO model. Poster presented at the European Association for the Study of the Liver Annual Meeting 2016 April 13–17, 2016 in Barcelona Spain.
He T, Li K, Roberts MS, Spaulding AC, Ayer T, Grefenstette JJ, Chhatwal, J. Prevention of hepatitis C by screening and treatment in US prisons. Ann Intern Med. 2015;164(2):84–92.
Varan AK, Mercer DW, Stein MS, Spaulding AC. Hepatitis C seroprevalence among prison inmates since 2001: still high but declining. Public Health Rep. 2014;129(2):187–95.
Surveillance for viral hepatitis—United States, 2011, http://www.cdc.gov/hepatitis/Statistics/2011Surveillance/Commentary.htm
(2014, accessed 27 March 2015).
Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment—Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology. 2010;52(3):1123–33.CrossRefGoogle Scholar
Livingston SE, Townshend-Bulson LJ, Bruden DL, et al. Treatment eligibility in Alaska native and American Indian persons with hepatitis C virus infection. Int J CircumpolarHealth. 2012;71:1–7.Google Scholar
Reilley B, Leston J, Redd JT, et al. Lack of access to treatment as a barrier to HCV screening: a facility-based assessment in the Indian health service. J Public Health Manag Pract. 2014;20(4):420–3.CrossRefPubMedGoogle Scholar
Pindyck T, Kalishman S, Flatow-Trujillo L, Thornton K. Treating hepatitis C in American Indians/Alaskan Natives: A survey of Project ECHO®(Extension for Community Healthcare Outcomes) utilization by Indian Health Service providers. SAGE Open Med. 2015;3:2050312115612805.CrossRefPubMedPubMedCentralGoogle Scholar
Thornton K et al. Response guided therapy is not dead: low sustained virologic response (SVR) rates in patients with detectable hepatitis C virus (HCV) at week 4 of treatment with sofosbuvir (SOF)-containing Regimens” 50th Annual Meeting of the European Association for the Study of Liver International Liver Congress, Vienna, Austria, April 22–26, 2015. Poster Presentation.
Thornton K, et al. Low Sustained Virologic Response (SVR) Rates in Genotype (GT) 2 and 3 Patients with Quantifiable Hepatitis C Virus (HCV) at Week 4 of Treatment with Sofosbuvir (SOF)-containing Regimens. 51st Annual Meeting of the European Association for the Study of Liver International Liver Congress, Barcelona Spain, April 13–17, 2016. Poster Presentation.
Thornton K, et al. Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment? Accepted for publication in Hepatology International 2016;20:1–8.
Hirnschall G. Towards the Elimination of Hepatitis B and C by 2030 The draft WHO Global Health Strategy. Glasgow: World Hepatitis Summit; 2015. p. 2–5.Google Scholar
National Academies of Sciences, Engineering, and Medicine. Eliminating the public health problem of hepatitis B and C in the United States: Phase one report. Washington, DC: The National Academies Press; 2016.Google Scholar
Stvilia K, Tsertsvadze T, Sharvadze L, et al. Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T’bilisi, Republic of Georgia. J Urban Health. 2006;83:289–98.CrossRefPubMedPubMedCentralGoogle Scholar
Mitruka K, Tsertsvadez T, Butsashvili M, Gamkrelidze A, Sabelashvili P, Adamia E. Launch of a Nationwide Hepatitis C Elimination Program—Georgia, MMWR Morb Mortal Wkly Rep. 2015;64(28):753–57.
Arora S et al. Partnering urban academic medical centers and rural primary care clinicians to provide complex chronic disease care. Health Aff. 2011;30(6):1176–84.CrossRefGoogle Scholar
Bankhurst A et al. Expanding access in rheumatology specialty care in new mexico via an innovative community outreach program. Arthritis Rheumatism. 2012;64:10.Google Scholar
Catic A, Mattison M, Lipsitz L. ECHO-AGE: a video-consultation program to bring geriatric expertise to long-term care. J Am Geriatr Soc. 2013;61:111.CrossRefGoogle Scholar
Catic A et al. ECHO-AGE: an innovative model of geriatric care for long-term care residents with dementia and behavioral issues. J Am Med Dir Assoc. 2014;15(12):938–42.CrossRefPubMedGoogle Scholar
Colleran K et al. Building capacity to reduce disparities in diabetes training community health workers using an integrated distance learning model. Diabetes Educ. 2012;38(3):386–96.CrossRefPubMedGoogle Scholar
Cordasco KM et al. VHA’S comprehensive women’s health SCAN-ECHO program: lessons learned. J Gen Intern Med. 2014;29:233.Google Scholar
Deming P et al. Project ECHO: a novel model for clinical pharmacists in a multidisciplinary Telehealth care network for rural and underserved communities. Pharmacotherapy. 2013;33:10.Google Scholar
Davis R, et al. Air force diabetes center of excellence project ECHO: successful telemedicine with a global reach diabetes. Amer Diabetes Assoc. 2015;64:A197–A197.
Dubin RE, et al. ECHO Ontario Chronic Pain & Opioid Stewardship: providing access and building capacity for primary care providers in underserviced, rural, and remote communities. Studies in Health Technology and Informatics. 209 2014: 15–22
Frank J, et al. Evaluation of a telementoring intervention for pain management in the Veterans Health Administration. Pain Med. 2015;16(6):1090–100.
Gordon SE, et al. Project ECHO-AGE and nursing home quality of care. J Am Med Dir Assoc. 2015;16(3):B27–8.
Harkins M et al. Project ECHO: Improving asthma care in New Mexico with telehealth technology. CHEST J. 2011;140(4):861A.CrossRefGoogle Scholar
Ho M, et al. The VA’s specialty care transformational initiatives to improve access and delivery of specialty care. J Gen Intern Med. 2013;28:S447–8.
Katzman JG et al. UNM ECHO-pain and headache program. Headache. 2012;52:5.Google Scholar
Katzman JG. Making connections: using telehealth to improve the diagnosis and treatment of complex regional pain syndrome, an underrecognized neuroinflammatory disorder. J Neuroimmune Pharmacol. 2013;8(3):489–93.CrossRefPubMedGoogle Scholar
Katzman JG et al. Innovative telementoring for pain management: project ECHO pain. J Contin Educ Health Prof. 2014;34(1):68–75.CrossRefPubMedGoogle Scholar
Kauth MR et al. Teleconsultation and training of VHA providers on transgender care: implementation of a multisite hub system. Telemed E-Health. 2015;21(12):1012–8.CrossRefGoogle Scholar
Khatri K, Haddad M, Anderson D. Project ECHO: replicating a novel model to enhance access to hepatitis C care in a community health center. J Health Care Poor Underserved. 2013;24(2):850–8.CrossRefPubMedGoogle Scholar
Knoefel J, Herman C. Dementia care training for primary care providers: Project ECHO™. Neurol Suppl. 2015;84(184):P6–182.Google Scholar
Marr L, Neale D. Project ECHO: bringing palliative care consultation to rural New Mexico through a novel telemedicine format. J Pain Symptom Manag. 2012;243(2):448–9.CrossRefGoogle Scholar
Mitruka K et al. Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model: Arizona and Utah, 2012–2014. MMWR Morb Mortal Wkly. 2014;63:393–8. One of the first published articles demonstrating the efficacy of the ECHO model for hepatitis C in a locale other than New Mexico.
Moore A, Manch R. Synchronous cohorts: a novel variation to the Project ECHO approach to hepatitis C treatment. Hepatology. 2013;58:111.Google Scholar
Salgia RJ et al. The educational impact of the specialty care access network–extension of community healthcare outcomes program. Telemed E-Health. 2014;20(11):1004–8.CrossRefGoogle Scholar
Scott JD et al. Project ECHO: a model for complex, chronic care in the Pacific Northwest region of the United States. J Telemed Telecare. 2012;18(8):481–4.CrossRefPubMedPubMedCentralGoogle Scholar
Socolovsky C et al. Evaluating the Role of Key Learning Theories in ECHO: A Telehealth Educational Program for Primary Care Providers Progress in community health partnerships: research, education, and action. 2013. p. 361–8.Google Scholar
Watts SA, et al. Improved glycemic control in veterans with poorly controlled diabetes mellitus using a Specialty Care Access Network-Extension for Community Healthcare Outcomes model at primary care clinics. J Telemed Telecare. 2015;22(4):221–4.
Wong JB, et al. Cost-effectiveness of hepatitis C treatment by primary care providers supported by the Extension for Community Healthcare Outcomes (ECHO) model. Hepatology. 2013;58:330A–330A.
Su GL, et al. Implementation of the first Department of Veterans Affairs Specialty Care Access Network-Extension of Community Healthcare Outcomes (SCAN-ECHO) program for chronic liver disease. Hepatology. 2012;56:259A–60A.
Lotvin A, Shrank W, Chang A. Harvoni® utilization in the weeks after launch: patterns and implications. 2014.Google Scholar